Anthony Martinelli is Founder and Editor-in-Chief of The Marijuana Herald, a daily marijuana news and information website that launched in 2018. You can reach Anthony at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
Jul 09 2025
Hawaii Governor Signs Law Requiring Hemp Retailers to Register With State, Sets Age Restriction on Tinctures
Hawaii Governor Josh Green has signed legislation that overhauls the state’s rules for hemp-derived products, including a mandate that retailers and distributors register with the Department of Health. The law, HB 1482, was signed on July 2 and will take effect January 1, 2026. It restricts sales of hemp-derived tinctures to those 21 and older, …
Jul 09 2025
Study: CBD Inhibits Osteosarcoma by Targeting Tumor-Driving Inflammation
A new study published in Phytomedicine finds that cannabidiol (CBD) can significantly inhibit the growth and spread of osteosarcoma, a highly aggressive bone cancer, by targeting a key inflammatory pathway. “Osteosarcoma remains a therapeutic challenge due to its aggressive behavior and high metastatic potential, necessitating exploration of novel treatment modalities”, states the study’s abstract. “Cannabidiol …
Jul 09 2025
New Mexico Marijuana Sales Reach $286 Million in 2025, Nearly $1.8 Billion All-Time
Licensed marijuana stores in New Mexico sold $47,024,514.08 worth of marijuana and marijuana products in June, This brings the state’s year-to-date total to $286,670,851, an 8% increase from the same period in 2024. Of the June total, $35,820,868.69 came from adult-use sales, while medical sales accounted for $11,203,645.43, according to new data released by the …
Jul 08 2025
Senior Advisor to President Trump’s Never Surrender PAC Says “It’s Illogical That Cannabis Is Classified As More Dangerous Than Fentanyl”
Alex Bruesewitz, a senior advisor to President Trump’s Never Surrender PAC, says it makes no sense that marijuana is federally classified as more dangerous than fentanyl. In a post on X, Bruesewitz called the classification “illogical,” noting that President Trump has expressed support for rescheduling marijuana to Schedule III. That move would maintain marijuana’s federal …
Jul 08 2025
U.S. Senate Committee Set to Consider Nationwide Hemp THC Ban on Thursday
The U.S. Senate Appropriations Committee is set to meet Thursday to discuss and potentially vote on an agriculture spending bill that is expected to contain language banning all consumable hemp products with any measurable amount of THC. Multiple sources in the cannabis industry say the provision is being pushed by Senator Mitch McConnell (R-KY), who …
Jul 08 2025
Missouri Marijuana Sales Total $125 Million in June, Bringing All-Time Revenue to $4.16 Billion
Missouri retailers sold more than $125 million worth of marijuana in June, according to new data released by the Department of Health and Senior Services. Of the $125.08 million in total sales, $110.63 million came from the adult-use market, while $14.45 million came from medical marijuana purchases. While slightly below May’s record-setting $132.81 million, June’s …
Jul 08 2025
Pew Poll: 87% of Americans Support Marijuana Legalization in Some Form
A new analysis from the Pew Research Center finds that a staggering 87% of Americans support legalizing marijuana in some capacity—either for medical, recreational, or both uses. The analysis reveals that public support for marijuana legalization remains strong, with nearly nine in 10 Americans favoring legalization in some form. According to the Center’s January–February 2025 …
Jul 08 2025
Washington D.C. Marijuana Sales Top $5.78 Million in May, Setting New Monthly Record
Washington D.C.’s medical marijuana industry continues to set records in 2025, with licensed dispensaries reporting $5,785,041 in sales during the month of May—the highest monthly total since the program launched more than a decade ago. That figure narrowly surpasses the previous high of $5.46 million recorded in April and more than doubles the $2.73 million …
Jul 07 2025
FDA Approves Psilocybin Trial for Veterans and First Responders With PTSD and Alcohol Use Disorder
A new clinical trial using a botanical psilocybin drug to treat co-occurring PTSD and alcohol use disorder (AUD) in veterans and first responders has received approval from the U.S. Food and Drug Administration. A new clinical trial using a botanical psilocybin drug to treat co-occurring PTSD and alcohol use disorder (AUD) in veterans and first …
Jul 07 2025
Study: Cannabidivarin (CBDV) May Help Improve Motor Coordination and Cognitive Function in Rhett Syndrome Patients
Researchers from Universidade de Lisboa and the Gulbenkian Institute of Molecular Medicine have found that chronic administration of cannabidivarin (CBDV), a non-intoxicating cannabinoid, may help alleviate some symptoms of Rett Syndrome in a female mouse model of the disorder. Rett Syndrome is a rare neurodevelopmental condition caused primarily by mutations in the MECP2 gene, which …
